SCHEMBL4353493

SCHEMBL4353493

CC12CN(C(=O)c3ccc4c(c3)OC([N+](=O)[O-])CO4)CC(C)(CN(C(=O)c3ccc4c(c3)OC([N+](=O)[O-])CO4)C1)C2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.43
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TSHR P16473 2/20 0.40
GAA P10253 2/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350306 0.88 HPGD (0.42) HPGDALDH1A1SMN1; SMN2MAPTCYP1A2
SCHEMBL4345772 0.81 HPGD (0.43) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4343757 0.80 HPGD (0.42) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4342175 0.80 HPGD (0.62) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4349432 0.78 HPGD (0.40) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4345617 0.78 HPGD (0.42) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4347843 0.77 HPGD (0.61) HPGDALDH1A1SMN1; SMN2MAPTCYP1A2
SCHEMBL4341694 0.69 HPGD (0.42) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4350374 0.68 HPGD (0.41) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4354055 0.67 HPGD (0.41) HPGDALDH1A1SMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2088149-A1 PHARMACOLOGICALLY ACTIVE N,N'-SUBSTITUTED 3,7-DIAZABICYCLO Ý3.3.1¨NONANES, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND A METHOD FOR THE USE THEREOF Institute of Physiologically active compunds of the Russian Academy of Sciences (IPAC RAN) (RU) 2009-08-12 EP claimed
EP-2088149-A1 PHARMACOLOGICALLY ACTIVE N,N'-SUBSTITUTED 3,7-DIAZABICYCLO Ý3.3.1¨NONANES, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND A METHOD FOR THE USE THEREOF Institute of Physiologically active compunds of the Russian Academy of Sciences (IPAC RAN) (RU) 2009-08-12 EP disclosed